Evidence map›Paper›PMID 28882890›Full record

ArticleThe Journal of biological chemistry2017

C-terminal phosphorylation of Na

Sophie Burel, Fabien C Coyan, Maxime Lorenzini, Matthew R Meyer, Cheryl F Lichti, Joan H Brown, Gildas Loussouarn, Flavien Charpentier, Jeanne M Nerbonne, R Reid Townsend and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 4 countries.

Sophie BurelFrom the l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, Nantes 44007, France.
Fabien C CoyanFrom the l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, Nantes 44007, France.
Maxime LorenziniFrom the l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, Nantes 44007, France.
Matthew R Meyerthe Departments of Medicine.
Cheryl F Lichtithe Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555.
Joan H Brownthe Department of Pharmacology, University of California at San Diego, La Jolla, California 92093-0636, and.
Gildas LoussouarnFrom the l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, Nantes 44007, France.
Flavien CharpentierFrom the l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, Nantes 44007, France.
Jeanne M NerbonneDevelopmental Biology.
R Reid TownsendInternal Medicine, and.
Lars S Maierthe Department of Internal Medicine II, University Heart Center, University Hospital Regensburg, D-93042 Regensburg, Germany.
Céline MarionneauFrom the l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, Nantes 44007, France, celine.marionneau@univ-nantes.fr.
Institut du Thorax · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitute of Developmental Physiology · RUThe University of Texas Medical Branch at Galveston · USUniversity Hospital Regensburg · DEUniversity of California, San Diego · USWashington University in St. Louis · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Program AdministrationP01HL080101 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2006 to 2015
$23.4M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
ION CHANNEL REGULATION AND MODULATION IN CARDIAC MUSCLER01HL034161 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 1986 to 2015
$4.6M
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical ProjectsR24GM136766 · NIGMS · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 2020 to 2022
$2.3M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NHLBI NIH HHS P01 HL080101NHLBI NIH HHS R01 HL034161NIGMS NIH HHS P41 GM103422NIGMS NIH HHS R24 GM136766
6 · The paper itself

Abstract

Voltage-gated Na

Indexed as

Ion Channel GatingAmino Acid SubstitutionAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Fibroblast Growth FactorsHeart FailureHEK293 CellsHumansMiceMice, TransgenicMutation, MissenseNAV1.5 Voltage-Gated Sodium ChannelPhosphorylationCalcium-Calmodulin-Dependent Protein Kinase Type 2fibroblast growth factor 13Fibroblast Growth FactorsNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanScn5a protein, mouseCa2+/calmodulin-dependent protein kinase II (CaMKII)calmodulin (CaM)channel inactivationFGF13heartNav1.5phosphoproteomicsphosphorylationsodium channel

Identifiers

PMID28882890
PMCPMC5655519
OpenAlexW2751216183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.